Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results

This publication has 24 references indexed in Scilit:

• Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing
  Urology, 2002
• Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer
  Urology, 2002
• DNA‐Based Detection of Prostate Cancer in Blood, Urine, and Ejaculates
  Annals of the New York Academy of Sciences, 2001
• THE USE OF TELOMERASE ACTIVITY FOR THE DETECTION OF PROSTATIC CANCER CELLS AFTER PROSTATIC MASSAGE
  Journal of Urology, 2001
• Detection of telomerase activity in prostatic fluid specimens
  Urologic Oncology: Seminars and Original Investigations, 2001
• Heterogeneous Nuclear Ribonucleoproteins C1 and C2 Associate with the RNA Component of Human Telomerase
  Molecular and Cellular Biology, 2000
• Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer
  Molecular and Cellular Probes, 2000
• A telomerase component is defective in the human disease dyskeratosis congenita
  Nature, 1999
• Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
  Nature Genetics, 1997
• Screening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the Evidence
  New England Journal of Medicine, 1995